Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Neurosci ; 25(13): 3400-13, 2005 Mar 30.
Article in English | MEDLINE | ID: mdl-15800195

ABSTRACT

The relationship between receptor-induced membrane phosphatidylinositol-4'5'-bisphosphate (PIP2) hydrolysis and M-current inhibition was assessed in single-dissociated rat sympathetic neurons by simultaneous or parallel recording of membrane current and membrane-to-cytosol translocation of the fluorescent PIP2/inositol 1,4,5-trisphosphate (IP3)-binding peptide green fluorescent protein-tagged pleckstrin homology domain of phospholipase C (GFP-PLCdelta-PH). The muscarinic receptor agonist oxotremorine-M produced parallel time- and concentration-dependent M-current inhibition and GFP-PLCdelta-PH translocation; bradykinin also produced parallel time-dependent inhibition and translocation. Phosphatidylinositol-4-phosphate-5-kinase (PI5-K) overexpression reduced both M-current inhibition and GFP-PLCdelta-PH translocation by both oxotremorine-M and bradykinin. These effects were partly reversed by wortmannin, which inhibits phosphatidylinositol-4-kinase (PI4-K). PI5-K overexpression also reduced the inhibitory action of oxotremorine-M on PIP2-gated G-protein-gated inward rectifier (Kir3.1/3.2) channels; bradykinin did not inhibit these channels. Overexpression of neuronal calcium sensor-1 protein (NCS-1), which increases PI4-K activity, did not affect responses to oxotremorine-M but reduced both fluorescence translocation and M-current inhibition by bradykinin. Using an intracellular IP3 membrane fluorescence-displacement assay, initial mean concentrations of membrane [PIP2] were estimated at 261 microm (95% confidence limit; 192-381 microm), rising to 693 microm (417-1153 microm) in neurons overexpressing PI5-K. Changes in membrane [PIP2] during application of oxotremorine-M were calculated from fluorescence data. The results, taken in conjunction with previous data for KCNQ2/3 (Kv7.2/Kv7.3) channel gating by PIP2 (Zhang et al., 2003), accorded with the hypothesis that the inhibitory action of oxotremorine-M on M current resulted from depletion of PIP2. The effects of bradykinin require additional components of action, which might involve IP3-induced Ca2+ release and consequent M-channel inhibition (as proposed previously) and stimulation of PIP2 synthesis by Ca2+-dependent activation of NCS-1.


Subject(s)
Cell Membrane/physiology , Neural Inhibition/physiology , Neurons/physiology , Phosphatidylinositol 4,5-Diphosphate/physiology , Receptors, Muscarinic/metabolism , Animals , Animals, Newborn , Bradykinin/pharmacology , Calcium/metabolism , Calcium-Binding Proteins/metabolism , Cell Membrane/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Interactions , Electric Stimulation/methods , Estrenes/pharmacology , Female , Fluorescent Dyes/metabolism , G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics , G Protein-Coupled Inwardly-Rectifying Potassium Channels/metabolism , Gene Expression/physiology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Immunohistochemistry/methods , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Microscopy, Confocal/methods , Muscarinic Agonists/pharmacology , Mutation/physiology , Neural Inhibition/drug effects , Neuronal Calcium-Sensor Proteins , Neurons/cytology , Neurons/drug effects , Neuropeptides/metabolism , Oxotremorine/analogs & derivatives , Oxotremorine/pharmacology , Patch-Clamp Techniques/methods , Phosphodiesterase Inhibitors/pharmacology , Phospholipase C delta , Pyrrolidinones/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Muscarinic/drug effects , Receptors, Muscarinic/genetics , Superior Cervical Ganglion/cytology , Transfection/methods , Type C Phospholipases/genetics , Type C Phospholipases/metabolism
2.
J Neurosci ; 23(12): 5012-9, 2003 Jun 15.
Article in English | MEDLINE | ID: mdl-12832524

ABSTRACT

KCNQ2 and KCNQ3 potassium-channel subunits can form both homomeric and heteromeric channels; the latter are thought to constitute native ganglionic M channels. We have tried to deduce the stoichiometric contributions of KCNQ2 and KCNQ3 subunits to currents generated by the coexpression of KCNQ2 and KCNQ3 cDNA plasmids in Chinese hamster ovary (CHO) cells, and to native M currents in dissociated rat superior cervical ganglion (SCG) neurons, by comparing the block of these currents produced by tetraethylammonium (TEA) with the block of currents generated by a tandem KCNQ3/2 construct. TEA concentration-inhibition curves against coexpressed KCNQ2 plus KCNQ3 currents, and against native M currents in SCG neurons from 6-week-old [postnatal day 45 (P45)] rats, were indistinguishable from those for the expressed tandem construct, and fully accorded with a 1:1 stoichiometry. Inhibition curves in neurons from younger (P17) rats could be better fitted assuming an additional small proportion of current carried by KCNQ2 homomultimers. Single-cell PCR yielded signals for KCNQ2, KCNQ3, and KCNQ5 mRNAs in all SCG neurons tested from both P17 and P45 rats. Quantitative PCR of whole-ganglion mRNA revealed stable levels of KCNQ2 and KCNQ5 mRNA between P7 and P45, but excess and incrementing levels of KCNQ3 mRNA. Increasing levels of KCNQ3 protein between P17 and P45 were confirmed by immunocytochemistry. We conclude that coexpressed KCNQ2 plus KCNQ3 cDNAs generate channels with 1:1 (KCNQ2:KCNQ3) stoichiometry in CHO cells and that native M channels in SCG neurons adopt the same conformation during development, assisted by the increased expression of KCNQ3 mRNA and protein.


Subject(s)
Neurons/metabolism , Potassium Channels/biosynthesis , Superior Cervical Ganglion/metabolism , Tetraethylammonium/pharmacology , Animals , CHO Cells , Cricetinae , Dose-Response Relationship, Drug , Humans , Immunohistochemistry , KCNQ Potassium Channels , KCNQ2 Potassium Channel , KCNQ3 Potassium Channel , Kinetics , Neurons/cytology , Neurons/drug effects , Potassium Channel Blockers/pharmacology , Potassium Channels/drug effects , Potassium Channels/genetics , Potassium Channels, Voltage-Gated , Protein Subunits/biosynthesis , Protein Subunits/drug effects , Protein Subunits/genetics , RNA, Messenger/biosynthesis , Rats , Reverse Transcriptase Polymerase Chain Reaction , Superior Cervical Ganglion/cytology , Superior Cervical Ganglion/drug effects , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL